Cryo-Cell International, Inc.
(NYSE Amex Equities : CCEL)

( )
CCEL PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Transportation » Other Transportation
LYFTLyft, Inc. -0.36%13.700.0%$210.96m
CPCanadian Pacific Railway Ltd. -1.76%69.730.1%$160.17m
SYYSysco Corp. -2.31%73.282.7%$159.20m
GRABGrab Holdings Ltd. (Singapore) 5.25%3.010.0%$64.38m
PFGCPerformance Food Group Co. -1.61%45.991.5%$43.43m
VNTVontier Corp. -3.14%17.580.0%$29.07m
VRRMVerra Mobility Corp. 0.18%16.500.0%$18.77m
ASRGrupo Aeroportuario del Sureste SA de CV 1.08%208.850.4%$10.35m
PACGrupo Aeroportuario del Pacífico SAB de CV 2.66%140.700.6%$7.16m
MODVModivCare, Inc. 0.11%100.950.0%$6.66m
OMABGrupo Aeroportuario del Centro Norte SAB de CV -0.38%52.350.1%$2.82m
VTOLBristow Group, Inc. -3.59%25.790.0%$2.52m
BRDSBird Global, Inc. 0.44%0.390.0%$1.25m
CAAPCorporacion America Airports SA -1.52%7.120.0%$0.66m
HLBZHelbiz, Inc. -2.19%0.340.0%$0.38m

Company Profile

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.